BlackRock’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $111M | Buy |
6,404,999
+75,401
| +1% | +$1.31M | ﹤0.01% | 1954 |
|
2025
Q1 | $138M | Sell |
6,329,598
-148,391
| -2% | -$3.25M | ﹤0.01% | 1791 |
|
2024
Q4 | $207M | Buy |
6,477,989
+285,621
| +5% | +$9.11M | ﹤0.01% | 1646 |
|
2024
Q3 | $179M | Buy |
6,192,368
+397,096
| +7% | +$11.5M | ﹤0.01% | 1715 |
|
2024
Q2 | $222M | Buy |
5,795,272
+300,681
| +5% | +$11.5M | 0.01% | 1538 |
|
2024
Q1 | $323M | Buy |
5,494,591
+113,338
| +2% | +$6.66M | 0.01% | 1309 |
|
2023
Q4 | $322M | Buy |
5,381,253
+108,507
| +2% | +$6.5M | 0.01% | 1318 |
|
2023
Q3 | $201M | Sell |
5,272,746
-474,881
| -8% | -$18.1M | 0.01% | 1540 |
|
2023
Q2 | $524M | Sell |
5,747,627
-1,907,824
| -25% | -$174M | 0.01% | 907 |
|
2023
Q1 | $505M | Sell |
7,655,451
-48,743
| -0.6% | -$3.22M | 0.01% | 905 |
|
2022
Q4 | $398M | Buy |
7,704,194
+617,864
| +9% | +$31.9M | 0.01% | 1035 |
|
2022
Q3 | $484M | Buy |
7,086,330
+287,786
| +4% | +$19.7M | 0.02% | 840 |
|
2022
Q2 | $307M | Buy |
6,798,544
+874,624
| +15% | +$39.6M | 0.01% | 1205 |
|
2022
Q1 | $301M | Buy |
5,923,920
+58,208
| +1% | +$2.96M | 0.01% | 1348 |
|
2021
Q4 | $277M | Buy |
5,865,712
+399,521
| +7% | +$18.9M | 0.01% | 1495 |
|
2021
Q3 | $180M | Sell |
5,466,191
-204,541
| -4% | -$6.74M | 0.01% | 1783 |
|
2021
Q2 | $358M | Sell |
5,670,732
-216,216
| -4% | -$13.7M | 0.01% | 1315 |
|
2021
Q1 | $253M | Sell |
5,886,948
-128,000
| -2% | -$5.49M | 0.01% | 1555 |
|
2020
Q4 | $344M | Buy |
6,014,948
+34,687
| +0.6% | +$1.98M | 0.01% | 1184 |
|
2020
Q3 | $180M | Sell |
5,980,261
-196,547
| -3% | -$5.93M | 0.01% | 1452 |
|
2020
Q2 | $202M | Buy |
6,176,808
+360,548
| +6% | +$11.8M | 0.01% | 1350 |
|
2020
Q1 | $156M | Buy |
5,816,260
+1,058,755
| +22% | +$28.4M | 0.01% | 1337 |
|
2019
Q4 | $146M | Buy |
4,757,505
+55,135
| +1% | +$1.69M | 0.01% | 1721 |
|
2019
Q3 | $113M | Buy |
4,702,370
+200,253
| +4% | +$4.82M | ﹤0.01% | 1815 |
|
2019
Q2 | $114M | Buy |
4,502,117
+781,085
| +21% | +$19.8M | ﹤0.01% | 1807 |
|
2019
Q1 | $72.6M | Sell |
3,721,032
-9,594
| -0.3% | -$187K | ﹤0.01% | 2065 |
|
2018
Q4 | $49.2M | Buy |
3,730,626
+877,431
| +31% | +$11.6M | ﹤0.01% | 2248 |
|
2018
Q3 | $50.7M | Buy |
2,853,195
+54,227
| +2% | +$964K | ﹤0.01% | 2349 |
|
2018
Q2 | $61.6M | Buy |
2,798,968
+1,692,121
| +153% | +$37.2M | ﹤0.01% | 2237 |
|
2018
Q1 | $24.5M | Buy |
1,106,847
+134,695
| +14% | +$2.98M | ﹤0.01% | 2641 |
|
2017
Q4 | $21.1M | Buy |
+972,152
| New | +$21.1M | ﹤0.01% | 2734 |
|